US 9375402
Oral formulations of kinase inhibitors
granted A61KA61K31/435A61K31/5377
Quick answer
US patent 9375402 (Oral formulations of kinase inhibitors) held by VERASTEM, INC. expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VERASTEM, INC.
- Grant date
- Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/435, A61K31/5377, A61K9/107, A61P